COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Medicine and Dentistry

• Hematologic Malignancy 70%
• Acute Myeloid Leukemia 30%
• Hematology 30%
• Intensive Care 20%
• Myelodysplastic Syndrome 20%
• Predictor 10%
• Diseases 10%
• Complication 10%
• Cause of Death 10%
• Adverse Outcome 10%
• Mortality Rate 10%
• Non-Hodgkin Lymphoma 10%
• Liver Disease 10%
• Heart Disease 10%
• Lymphoproliferative Disease 10%
• B-Cell Chronic Lymphocytic Leukemia 10%
• Myeloma 10%
• Clinical Management 10%

Agricultural and Biological Sciences

• Myeloid 100%
• Laboratories 33%
• Risk Factors 33%